![A nomogram based on clinicopathological features and serological indicators predicting breast pathologic complete response of neoadjuvant chemotherapy in breast cancer | Scientific Reports A nomogram based on clinicopathological features and serological indicators predicting breast pathologic complete response of neoadjuvant chemotherapy in breast cancer | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-91049-x/MediaObjects/41598_2021_91049_Fig1_HTML.png)
A nomogram based on clinicopathological features and serological indicators predicting breast pathologic complete response of neoadjuvant chemotherapy in breast cancer | Scientific Reports
![Frontiers | Investigation of the efficacy and safety of cryoablation and intra-arterial PD-1 inhibitor in patients with advanced disease not responding to checkpoint inhibitors: An exploratory study Frontiers | Investigation of the efficacy and safety of cryoablation and intra-arterial PD-1 inhibitor in patients with advanced disease not responding to checkpoint inhibitors: An exploratory study](https://www.frontiersin.org/files/Articles/990224/fimmu-13-990224-HTML/image_m/fimmu-13-990224-t002.jpg)
Frontiers | Investigation of the efficacy and safety of cryoablation and intra-arterial PD-1 inhibitor in patients with advanced disease not responding to checkpoint inhibitors: An exploratory study
![Neoadjuvant treatment of HER 2-positive breast cancer – pathological complete response ( pCR ) as a surrogate of long term outcomes in the context of regulatory guidelines and reimbursement recommendations | Semantic Scholar Neoadjuvant treatment of HER 2-positive breast cancer – pathological complete response ( pCR ) as a surrogate of long term outcomes in the context of regulatory guidelines and reimbursement recommendations | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2da9c7d2a6f39a0fe209056652e3f8b8a0df708e/4-Table1-1.png)